Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Cancer Res. 2020 Jul 24;26(21):5701–5708. doi: 10.1158/1078-0432.CCR-20-1825

Figure 2.

Figure 2.

Genomic context of SMARCA4 alterations. (A) Most frequent co-occurring alterations by SMARCA4 alteration. (B) Distribution of SMARCA4 alteration by commonly altered gene subgroups in NSCLC. (C) Frequency of altered individual genes within SMARCA4 mutant vs SMARCA4 wildtype subgroups. Genes labeled red were associated with significantly differential PD-L1 expression (q value <0.10). (D) Distribution of SMARCA4, STK11, KRAS, and KEAP1 alterations within NSCLC cohort.